SCHEMBL7000604

SCHEMBL7000604

Clc1ccc2c(c1)OCc1cccnc1C2Cl

nearest known ligand 0.43

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FNTA P49354 6/20 0.42
FNTB P49356 6/20 0.42
MAP3K14 Q99558 1/20 0.39
MAPT P10636 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
P2RX7 Q99572 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13681920 0.85 TERT (0.40) FNTAFNTBMAPT
SCHEMBL6991517 0.85 MAP3K14 (0.44) FNTAFNTBMAP3K14P2RX7
SCHEMBL1978262 0.78 FNTA (0.60) FNTAFNTB
SCHEMBL7000351 0.77 FNTA (0.71) FNTAFNTB
SCHEMBL6991223 0.74 FNTA (0.52) FNTAFNTB
SCHEMBL9261841 0.72 FNTA (0.54) FNTAFNTB
SCHEMBL11277012 0.72 HTR2B (0.40) MAP3K14MAPTRXFP1
SCHEMBL9563101 0.71 FNTA (0.60) FNTAFNTB
SCHEMBL6998860 0.69 FNTA (0.49) FNTAFNTB
SCHEMBL38663475 0.68 FNTA (0.47) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585864-B2 Farnesyl protein transferase inhibitors and their use to treat cancer SCHERING CORPORATION (US) 2009-09-08 US disclosed
US-7585864-B2 Farnesyl protein transferase inhibitors and their use to treat cancer SCHERING CORPORATION (US) 2009-09-08 US disclosed
EP-1021448-B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORP (US) 2003-05-02 EP disclosed
US-6130229-A Tricyclic compounds having activity as RAS-FPT inhibitors SCHERING CORPORATION (US) 2000-10-10 US disclosed
EP-1021448-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORPORATION (US) 2000-07-26 EP disclosed
WO-1998015556-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORPORATION (US) 1998-04-16 WO disclosed
EP-0535152-B1 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylene and piperazine compounds as PAF antagonists and compositions thereof. SCHERING CORP (US) 1995-08-09 EP disclosed
US-5430032-A Treating asthma, allergy, inflammation SCHERING CORPORATION (US) 1995-07-04 US disclosed
US-5422351-A Antiallergens; antiinflammatory agents SCHERING CORPORATION (US) 1995-06-06 US disclosed
EP-0595989-A1 BENZOPYRIDO PIPERYLIDENE COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE AND METHODS OF USE SCHERING CORPORATION (US) 1994-05-11 EP disclosed
EP-0535152-A1 BIS-BENZO OR BENZOPYRIDO CYCLO HEPTA PIPERIDENE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS AND COMPOSITIONS. SCHERING CORP (US) 1993-04-07 EP disclosed
WO-1993002081-A1 NOVEL BENZOPYRIDO PIPERYLIDENE COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE AND METHODS OF USE SCHERING CORPORATION (US) 1993-02-04 WO disclosed
EP-0524784-A1 Benzopyrido piperidylidene compounds as PAF antagonists SCHERING CORPORATION (US) 1993-01-27 EP disclosed
WO-1992000293-A1 BIS-BENZO OR BENZOPYRIDO CYCLO HEPTA PIPERIDENE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1992-01-09 WO disclosed